1. Alfsen, G.C., Reed, W., Sandstad, B., Kristensen, G.B. & Abeler, V.M. (2003) The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma. Cancer, 98, 1880-1889.
2. Angioli, R., Plotti, F., Montera, R., Aloisi, A., Luvero, D., Capriglione, S., Terranova, C., De Cicco Nardone, C., Muzii, L. & Benedetti-Panici, P. (2012) Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer. Gynecol. Oncol., 127, 290-296.
3. Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J. & Bray, F. (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health, 8, e191-e203.
4. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration (CCCMAC) (2010) Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst. Rev., 2010, CD008285.
5. Chen, X., Zou, H., Li, H., Lin, R., Su, M., Zhang, W., Zhou, Y., Zhang, P., Hou, M., Deng, X. & Zou, C. (2017) Weekly versus triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of cervical cancer: a meta-analysis. Int. J. Gynecol. Cancer, 27, 344-349.